Edition:
India

People: Agios Pharmaceuticals Inc (AGIO.OQ)

AGIO.OQ on NASDAQ Stock Exchange Global Select Market

48.05USD
14 Jun 2019
Change (% chg)

-- (--)
Prev Close
$48.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
167,261
52-wk High
$99.77
52-wk Low
$41.63

Miles, Darrin 

Mr. Darrin Miles is Senior Vice President, U.S. Commercial and Global Marketing of the company. Mr. Miles has more than 20 years of experience across a range of commercial and program management roles in pharmaceuticals and biotechnology. He joined Agios in 2015 as vice president, oncology marketing and market analytics and most recently served as vice president, oncology program leadership, where he has been instrumental in setting the strategy for the IDH portfolio and leading the program team through the development and approval of TIBSOVO ® . Prior to joining Agios, Mr. Miles spent 14 years at Genentech, where he held roles of increasing responsibility including marketing, sales management, reimbursement and lifecycle leadership supporting a broad portfolio of brands including Rituxan ® , Herceptin ® , Tarceva ® and Lucentis ® . He also led the U.S. launches of next generation anti-HER2 treatments Perjeta ® and Kadcyla ® . Prior to Genentech, Mr. Miles spent a number of years at ALZA Corporation and SmithKline Beecham (now GSK) in numerous roles including marketing, market analytics and organization development. Mr. Miles holds a B.S. in applied economics with a minor in biological sciences from Cornell University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Schenkein

8,199,320

Jacqualyn Fouse

537,891

Andrew Hirsch

3,136,860

Darrin Miles

--

Scott Biller

3,098,050

Christopher Bowden

3,128,730
As Of  31 Dec 2018